Risk factors for the emergence of multidrug-resistant organisms in liver cirrhosis

Bartoletti, 2017, Opportunistic infections in end stage liver disease, Infect Dis Rep, 9, 7621 Jalan, 2014, Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013, J Hepatol, 60, 1310, 10.1016/j.jhep.2014.01.024 Zhao, 2018, Multidrug-resistant bacterial infections in cirrhotic patients: an epidemiological study, Expert Rev Gastroenterol Hepatol, 12, 1167, 10.1080/17474124.2018.1515627 Piano, 2018, Infections complicating cirrhosis, Liver Int, 38, 126, 10.1111/liv.13645 Mücke, 2018, Bacterial infection-triggered acute-on-chronic liver failure is associated with increased mortality, Liver Int, 38, 645, 10.1111/liv.13568 Fernández, 2019, Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe, J Hepatol, 70, 398, 10.1016/j.jhep.2018.10.027 Gupta, 2019, Prediction of 28-day mortality in acute decompensation of cirrhosis through the presence of multidrug-resistant infections at admission, J Gastroenterol Hepatol Lameirão Gomes, 2019, Bacterial infections in patients with liver cirrhosis in an Internal Medicine Department, GE Port J Gastroenterol, 26, 324, 10.1159/000494568 Moreau, 2013, Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis, Gastroenterology, 144, 1426, 10.1053/j.gastro.2013.02.042 Piano, 2019, Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide, Gastroenterology, 156, 10.1053/j.gastro.2018.12.005 Jain, 2017, An insight into antibiotic resistance to bacterial infection in chronic liver disease, J Clin Exp Hepatol, 7, 305, 10.1016/j.jceh.2017.05.003 Fernandez, 2012, Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study, Hepatology, 55, 1551, 10.1002/hep.25532 De Roza, 2019, Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis, World J Gastroenterol, 25, 4933, 10.3748/wjg.v25.i33.4933 Janka, 2019, Deleterious effect of proton pump inhibitors on the disease course of cirrhosis, Eur J Gastroenterol Hepatol Dam, 2019, Effect of proton pump inhibitors on the risk and prognosis of infections in patients with cirrhosis and ascites, Liver Int, 39, 514, 10.1111/liv.14012